+1-888-308-5802     
News Contact Us

Carcinoembryonic Antigen Market statistics and research analysis released in latest report

Author : Rahul Sankrityayan | Published Date : 2019-04-12 

Carcinoembryonic Antigen Market size is set to reach USD 3.0 billion by 2024; according to a new research study published by Global Market Insights, Inc.
 
Rising geriatric population base coupled with growing number of cancer diseases is driving the carcinoembryonic antigen market size over the forecast timeframe. According to the World Health Organization, cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. Additionally, worldwide, about 1 in 6 deaths is due to cancer. All these factors will propel the global market growth.

Constant advancement in technology such as proteomics that includes mass spectrometry, protein bioinformatics, protein labelling, imaging and array-based approaches with the development of new biomarkers that can be used in combination with other biomarkers is anticipated to fuel the demand for carcinoembryonic antigen market growth during the forecast timeframe. Favorable government initiatives for the improvement of diagnostic rates and the advancement of new combination biomarkers has immense growth opportunities for carcinoembryonic antigen market. Hence, it will result in increasing demand for effective carcinoembryonic antigen tests, thereby fueling business growth.

Request sample copy of this report @ www.gminsights.com/request-sample/detail/427

The inability of carcinoembryonic antigen tests to detect early stage cancer will be a major market impeding factor. In addition, lack of awareness regarding the application of carcinoembryonic antigen tests will decrease the demand, thus hindering the market growth.

Gastrointestinal cancer market was valued around USD 652.4 million in the year 2017.  According to an article published in the National Center for Biotechnology Information, gastrointestinal cancer is the fourth most common malignancy worldwide and remains the second most common cause of death  of all malignancies globally, hence driving the market growth for carcinoembryonic antigen.
 
Breast cancer market is estimated to grow at a CAGR of 7.3% over the projection period. Breast cancer is the most common cancer affecting the women population. Furthermore, breast cancer diagnosis involves three tumor markers, one of them being carcinoembryonic antigen; carcinoembryonic antigen tests have been used to help monitor metastatic breast cancer (advanced disease), that will propel the industry growth in the forthcoming years.
 
Make Inquiry about this report @ www.gminsights.com/inquiry-before-buying/427

Males in carcinoembryonic antigen market was valued around USD 1,003.2 million in the year 2017. The rationale for greater market share in men carcinoembryonic antigen market is the greater frequency of cancer diagnosis, rather than poorer survival once the cancer is diagnosed at a late stage. Furthermore, lifestyle-related factors such as smoking, drinking increasing amounts of alcohol, putting on weight, and taking less exercise are also responsible for the largest share of males in carcinoembryonic antigen market.
 
The hospitals market is projected to grow at a considerable CAGR of 6.1% over the forecast timeframe owing to increasing number of hospital admissions. Geriatric population suffering from cancers requiring continuous monitoring prefer minimally invasive procedures carried out in hospitals and clinics, that will boost the market growth.
 
U.S. market is estimated to grow at robust CAGR of 6.0% during the projection period. Increase in number of geriatric population affected with cancer, advancements in carcinoembryonic antigen tests, greater patient and physician awareness regarding early disease detection and availability of low-cost tests across broader settings of care are some of the major factors contributing to largest market share in the region.
 
Japan dominated the Asian market and was valued around USD 74.6 million in the year 2017. Growing awareness about pre-disease diagnosis and prevention will further drive the market growth. Additionally, rising per capita healthcare expenditure and growing demand for rapid and cost effective carcinoembryonic antigen tests will fuel the market growth in Japan.
 
Some of the leading players in the carcinoembryonic antigen market include F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biological Technology. These companies opt for strategic decisions such as mergers, acquisitions, and partnerships in order to increase their efficiency and sustain in the market.

About Author

Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for Fractovia, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in technical field as well as writing. He can be contacted at- [email protected] | https://twitter.com/sankritsays

Related News

Synthetic Food Market Projections, Industry Outlook, Business Outlook by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has released a new research study on Synthetic Food Market analysis 2018-2023 inclusive of one or more factors covering regional opportunities, application landscape, product demand trends, and end-use portfolio of the industry over the forecast timeframe. The repor... Read More

Non-Alcoholic Beer Market Insights, Industry Projections, Regional Analysis by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has announced the launch of Non-Alcoholic Beer Market, a comprehensive study enumerating the latest price trends and pivotal drivers rendering a positive impact on the industry landscape. Further, the report is inclusive of the competitive terrain of this vertical in add... Read More

Food Enzymes Market 2019 Analysis, Industry Strategy, Business Prospects by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has added a new report on Food Enzymes Market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also ... Read More

© 2019 Fractovia. All Rights Reserved